Ping An Biomedical Co Ltd (PASW) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access PASW quarterly Cash Flow →
The quarterly cash flow data below helps track how Ping An Biomedical Co Ltd's liquidity profile has evolved over recent quarters.
Annual Report, GAAP in USD millions
ITEM
(Sep 30 2025)
12 Months
Operating Activities
Income-1.80
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed1.31
Inventories Decrease /-Increase0.04
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Provision For Inventory Obsolescence0.00
Deferred Income Expense Benefit-0.21
Increase Decrease In Contract With Customer Liability-0.23
Increase Decrease In Advance From Related Parties0.05
Increase Decrease In Repayment Of Obligation Under Operating Leases-0.05
Income taxes-0.05
Losses/ -gains on Investments net0.00
Accounts Receivable-1.99
Accounts Payable-0.79
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.09
Other Working Capital0.00
Other Noncash Expense0.05
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-0.90
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Advances Related Parties-
Repayment To Related Parties-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net1.40
Other borrowing transactions0.00
Long-term debt - borrowings7.30
Long-term debt - repayments12.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock4.36
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.02
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents0.02
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities6.13
Effect of exchange rate on cash flow-0.09
Discontinued operations0.00
Free Cash Flow-0.90
Total Cash Flow5.23
4 historic quarters locked

Sign in to unlock the full Ping An Biomedical Co Ltd cash flow history.

About Ping An Biomedical Co Ltd Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-26-010078

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License